By Puya Partow-Navid

Seyfarth Synopsis: In 2022, the Federal Circuit definitively ruled that artificial intelligence (AI) systems cannot be named inventors or co-inventors on patent applications, reinforcing the longstanding principle that only natural persons are eligible as inventors under the Patent Act.  This decision, however, left an important question unanswered: Are inventions created with AI assistance patentable?

Today, the United

Continue Reading USPTO Guidelines Define the Role of AI in Patent Inventorship

By Tonya M. EspositoRenee B. Appel, and Jonathan Huie

Seyfarth Synopsis: CBD is “thriving” in the current regulatory environment, but is it doing so illegally?

As former U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb opined last week, “the CBD craze is getting out of hand. The FDA needs to act.” Since the passage
Continue Reading CBD is Everywhere – But Where Does the FDA Stand?

By Becki Lee

Seyfarth Synopsis: Regular readers will recall that in March we blogged about cannabis-related trademarks.  We now have an update:

On May 2, 2019, the USPTO distributed an Examination Guide updating their practices after passage of the 2018 Farm Bill on December 20, 2018. The Farm Bill removes “hemp” from the definition of “marijuana” in the
Continue Reading Likely to be Dazed and Confused – An Update